Announcements Trials
Browse Landscape

Phase

Phase NA 101Phase 3 3Phase 1 3Phase EARLY_PHASE1 2Phase 4 2Phase 2 2Phase 1/2 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Breast 1

Conditions

Urinary Bladder Neoplasms 1Tobacco Use Disorder 1Stress Disorders, Post-Traumatic 1Small Cell Lung Carcinoma 1Depression 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Paclitaxel 291Gemcitabine 254Carboplatin 253Cisplatin 250Radiotherapy 219Cyclophosphamide 218Irinotecan 184pembrolizumab 180Docetaxel 174Bevacizumab 166Capecitabine 148Nivolumab 141Fluorouracil 132Dexamethasone 125Bortezomib 123Oxaliplatin 115Cytarabine 113Erlotinib Hydrochloride 112Sorafenib 110Temozolomide 109Doxorubicin 106Rituximab 105Leucovorin 105Etoposide 105Filgrastim 99Everolimus 97Lenalidomide 95Ipilimumab 90Pemetrexed 89fludarabine phosphate 84

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Completed × Methods × Clear all
NCT04548193 2024-08-28

Behavioral Dietary Intervention for the Improvement of Bladder Cancer Survivorship

Roswell Park Cancer Institute

Phase 1 Completed
49 enrolled 12 charts
Genitourinary

Urinary Bladder Neoplasms

NCT01457469 2018-08-01

Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer

Wake Forest University Health Sciences

Phase 1 Completed
6 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Tobacco Use Disorder, Small Cell Lung Carcinoma

NCT01672684 2014-10-17

Phase I: At-Home Support for Rural Women Using Group Video Calling

Stanford University

Phase 1 Completed
34 enrolled
Breast

Breast Neoplasms, Depression, Stress Disorders, Post-Traumatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡